84 related articles for article (PubMed ID: 16338505)
1. The effect of treatment on the presence of abnormal heart sounds in emergency department patients with heart failure.
Collins SP; Lindsell CJ; Peacock WF; Hedger VD; Storrow AB
Am J Emerg Med; 2006 Jan; 24(1):25-32. PubMed ID: 16338505
[TBL] [Abstract][Full Text] [Related]
2. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
3. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea.
Collins SP; Peacock WF; Lindsell CJ; Clopton P; Diercks DB; Hiestand B; Hogan C; Kontos MC; Mueller C; Nowak R; Chen WJ; Huang CH; Abraham WT; Amsterdam E; Breidthardt T; Daniels L; Hasan A; Hudson M; McCord J; Naz T; Wagoner LE; Maisel A
Ann Emerg Med; 2009 Jun; 53(6):748-57. PubMed ID: 19232777
[TBL] [Abstract][Full Text] [Related]
4. Interrater reliability of hemodynamic profiling of patients with heart failure in the ED.
Chaudhry A; Singer AJ; Chohan J; Russo V; Lee C
Am J Emerg Med; 2008 Feb; 26(2):196-201. PubMed ID: 18272102
[TBL] [Abstract][Full Text] [Related]
5. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea.
Collins SP; Lindsell CJ; Peacock WF; Hedger VD; Askew J; Eckert DC; Storrow AB
J Card Fail; 2006 May; 12(4):286-92. PubMed ID: 16679262
[TBL] [Abstract][Full Text] [Related]
6. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
[TBL] [Abstract][Full Text] [Related]
7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Kirk JD; Parissis JT; Filippatos G
Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
[TBL] [Abstract][Full Text] [Related]
10. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure.
Bayes-Genis A; Pascual-Figal D; Fabregat J; Domingo M; Planas F; Casas T; Ordoñez-Llanos J; Valdes M; Cinca J
Int J Cardiol; 2007 Sep; 120(3):338-43. PubMed ID: 17174423
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dyslipidemia in the emergency department: impact of cholesterol testing on subsequent therapy.
Blomkalns AL; O'Connell EM; Eady CE; Lindsell CJ; Gibler WB
Am Heart J; 2006 Dec; 152(6):1182-6. PubMed ID: 17161073
[TBL] [Abstract][Full Text] [Related]
12. Acutely decompensated heart failure: characteristics of hospitalized patients and opportunities to improve their care.
Sarmento PM; Fonseca C; Marques F; Ceia F; Aleixo A
Rev Port Cardiol; 2006 Jan; 25(1):13-27. PubMed ID: 16623353
[TBL] [Abstract][Full Text] [Related]
13. Hospital policies for treatment of acute decompensated heart failure.
Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
[TBL] [Abstract][Full Text] [Related]
16. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up.
Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Dziamska M; Kaszuba D; Szymanowska K; Michalski M
Kardiol Pol; 2006 Oct; 64(10):1063-70; discussion 1071-2. PubMed ID: 17089238
[TBL] [Abstract][Full Text] [Related]
17. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
18. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
19. Beyond diuretics: management of volume overload in acute heart failure syndromes.
Hill JA; Yancy CW; Abraham WT
Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
